Atea Pharmaceuticals (AVIR) Stock Chart & Stock Price History $3.12 +0.01 (+0.16%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Atea Pharmaceuticals Stock Price Performance The Atea Pharmaceuticals (AVIR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 11.76%, with a year-to-date return of -7.01%. In the past month, the stock has decreased 0.80%, reflecting recent market activity. As of the latest close, Atea Pharmaceuticals traded at $3.11 with a market cap of $246.80 million and volume of 295,306 shares. Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.48%1 Month Performance-0.80%3 Month Performance-17.15%Year-To-Date Performance-7.01%1 Year Performance-11.76% AVIR Stock Chart for Tuesday, October, 14, 2025 AVIR Chart by TradingView Atea Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025$3.14$3.11-0.96%$3.15$3.01295,306 shs$246.80 million10/10/2025$3.13$3.14+0.32%$3.17$2.99360,005 shs$249.18 million10/09/2025$3.10$3.13+0.97%$3.16$3.08374,425 shs$248.40 million10/08/2025$2.97$3.10+4.38%$3.10$2.961.15 million shs$246.02 million10/07/2025$2.91$2.97+2.06%$3.06$2.901.05 million shs$235.69 million10/06/2025$2.90$2.91+0.34%$2.94$2.84475,956 shs$230.94 million10/03/2025$2.82$2.90+2.84%$2.92$2.81720,563 shs$230.14 million10/02/2025$2.88$2.82-2.08%$2.88$2.78718,522 shs$223.80 million10/01/2025$2.90$2.88-0.69%$2.94$2.86287,627 shs$228.55 million09/30/2025$2.92$2.90-0.68%$2.92$2.82255,375 shs$230.14 million Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025$2.93$2.92-0.34%$2.97$2.84267,300 shs$231.73 million09/26/2025$2.91$2.93+0.69%$2.95$2.89296,144 shs$232.53 million09/25/2025$2.90$2.91+0.34%$2.92$2.86208,844 shs$230.93 million09/24/2025$2.90$2.90$2.98$2.89157,921 shs$230.14 million09/23/2025$2.93$2.90-1.02%$2.96$2.87215,042 shs$230.14 million09/22/2025$2.88$2.93+1.74%$3.01$2.85267,615 shs$232.52 million09/19/2025$2.97$2.88-3.03%$3.03$2.85647,039 shs$228.55 million09/18/2025$2.91$2.97+2.06%$3.00$2.91323,928 shs$235.70 million09/17/2025$2.97$2.91-2.02%$3.00$2.84336,250 shs$230.94 million09/16/2025$3.04$2.97-2.30%$3.06$2.95155,570 shs$235.69 million09/15/2025$3.14$3.04-3.18%$3.15$3.02174,614 shs$241.25 million Related Companies CorMedix Stock Price Chart AnaptysBio Stock Price Chart Phathom Pharmaceuticals Stock Price Chart Tango Therapeutics Stock Price Chart Anavex Life Sciences Stock Price Chart Prime Medicine Stock Price Chart Iovance Biotherapeutics Stock Price Chart Arbutus Biopharma Stock Price Chart Xencor Stock Price Chart Kura Oncology Stock Price Chart Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVIR) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
